webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Q Bu-i

  CAS No.:   Cat No.: BADC-00312   Purity: ≥97%. (NMR) 4.5  

Q Bu-i is a potent ADC cytotoxin payload that targets microtubule dynamics, inducing apoptosis in cancer cells. Its application in antibody-drug conjugates facilitates targeted tumor eradication with minimized off-target effects.

Q Bu-i

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Cytotoxin
Molecular Formula
C11H22BrN
Molecular Weight
248.20
Shipping
Room temperature
Shipping
Store at room temperature in a dark place

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Solubility
Water, ethanol
Melting Point
282-284 °C.
Appearance
White powder.
Shipping
Room temperature
Storage
Store at room temperature in a dark place
1. Silver coordination chemistry of a new versatile "Janus"-type N(2),O(2)-bichelating donor, formation of an unprecedented supramolecular network of binuclear silver building blocks containing a five-coordinate beta-diketonate, and isolation of unexpected silver-tin-silver heterotrimetallic complexes from silver metathesis reactions
Augusto Cingolani, Brian W Skelton, Fabio Marchetti, Riccardo Pettinari, Allan H White, Claudio Pettinari, Effendy Effendy Inorg Chem . 2004 Jul 12;43(14):4387-99. doi: 10.1021/ic0497376.
Synthetic, spectroscopic, and single-crystal X-ray studies are reported for several complexes of silver(I) with the N(2),O(2)-bichelating Q(py) ligand (HQ(py) = 1-(2-pyridyl)-3-methyl-4-trifluoroacetylpyrazol-5-one). Direct interaction between HQ(py) and AgNO(3) in methanol, in the presence of NaOCH(3), affords derivative Ag(Q(py)), showing a polynuclear structure composed of dinuclear building blocks with two different Ag environments and two Q(py) donors differently connected. By adding neutral ligands such as PR(3) (R = Ph, Cy, C(6)H(4)-o-CH(3), C(6)H(4)-p-F, Bu(i)) to Ag(Q(py)), dinuclear Ag(Q(py))(PR(3)) derivatives have been isolated, containing bridging N(2),O-exotridentate Q(py) donors spanning a pair of AgPR(3) moieties. Reaction of Ag(Q(py))(PPh(3)) with excess PPh(3) produces the mononuclear Ag(Q(py))(PPh(3))(2) containing N(2)-chelate Q(py). Ag(Q(py)) interacts with 1,2-bis(diphenylphosphino)ethane (dppe) yielding the derivative Ag(Q(py))(dppe), having a polynuclear structure in the solid state which is seemingly disrupted in solution, with the formation of two new species, a mononuclear neutral compound and a dinuclear ionic one. By the interaction of Ag(Q(py)) with nitrogen donors L (L = imidazole (imH), 1-methylimidazole (Meim), 1-methyl-2-mercaptoimidazole (Hmimt), 1,10-phenanthroline (phen)), mononuclear species Ag(Q(py))(L) have been obtained, where Q(py) is coordinated to silver in N(2)-chelating mode. Ag(Q(py))(PPh(3))(2) reacts with SnRCl(3) (R = Ph, Bu(n)) affording heterotrimetallic [[(Ph(3)P)(2)AgCl](2)SnRCl(3)] derivatives.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Payload Development Biological Payload Chemical Payload Protein Toxin Nanocarrier Microtubule Inhibitors DNA Damaging Agents RNA Polymerase Inhibitors Protein Degraders

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Maytansine and Its Analogues Cytotoxic Agents Used in Antibody–Drug Conjugates Exatecan Mesylate in ADCs: A New Topo I Inhibitor What is Calicheamicin? What is Monomethyl Auristatin E (MMAE)? What is Monomethyl Auristatin F (MMAF)? What is Pyrrolobenzodiazepine (PBD)? Antiviral Potential of Thapsigargin in COVID-19 Research ADC Payloads Explained: Current Types and Cutting-Edge Research Progress Tubulin Inhibitors - Highly Potential ADC Payloads

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: M4-Nitrodienamine | Dihydroatisine HCl | 3-beta-iodo-Imperialine | M2-Nitrodienamine | Farletuzumab ecteribulin | Imperatoxin-Inhibitor | Donaxine iodomethylate | Muscarinic toxin 2 | M3-Nitrodienamine | M5-Nitrodienamine | Q Bu-i
Send Inquiry
Verification code
Inquiry Basket